Free Trial
NYSE:FMS

Fresenius Medical Care (FMS) Stock Price, News & Analysis

Fresenius Medical Care logo
$21.22 -0.18 (-0.84%)
(As of 11/12/2024 ET)

About Fresenius Medical Care Stock (NYSE:FMS)

Key Stats

Today's Range
$21.17
$21.38
50-Day Range
$19.11
$21.39
52-Week Range
$17.49
$22.76
Volume
131,588 shs
Average Volume
367,726 shs
Market Capitalization
$12.45 billion
P/E Ratio
17.53
Dividend Yield
2.07%
Price Target
$24.30
Consensus Rating
Hold

Company Overview

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
81st Percentile Overall Score

FMS MarketRank™: 

Fresenius Medical Care scored higher than 81% of companies evaluated by MarketBeat, and ranked 221st out of 986 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius Medical Care has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Fresenius Medical Care has only been the subject of 2 research reports in the past 90 days.

  • Read more about Fresenius Medical Care's stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius Medical Care are expected to grow by 22.22% in the coming year, from $1.53 to $1.87 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius Medical Care is 17.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.43.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius Medical Care is 17.53, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.90.

  • Price to Earnings Growth Ratio

    Fresenius Medical Care has a PEG Ratio of 0.98. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Fresenius Medical Care has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Fresenius Medical Care's valuation and earnings.
  • Percentage of Shares Shorted

    0.17% of the outstanding shares of Fresenius Medical Care have been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fresenius Medical Care has recently increased by 39.69%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Fresenius Medical Care pays a meaningful dividend of 2.08%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius Medical Care does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius Medical Care is 36.36%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius Medical Care will have a dividend payout ratio of 23.53% next year. This indicates that Fresenius Medical Care will be able to sustain or increase its dividend.

  • Read more about Fresenius Medical Care's dividend.
  • Percentage of Shares Shorted

    0.17% of the outstanding shares of Fresenius Medical Care have been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fresenius Medical Care has recently increased by 39.69%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Fresenius Medical Care has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Fresenius Medical Care this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for FMS on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.
  • MarketBeat Follows

    17 people have added Fresenius Medical Care to their MarketBeat watchlist in the last 30 days. This is an increase of 1,600% compared to the previous 30 days.
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

Berenberg Bank Begins Coverage on Fresenius Medical Care (NYSE:FMS)
Fresenius Medical ADRs initiated with a Buy at Berenberg
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Fresenius Medical Care Reports Strong Q3 2024 Results
Fresenius Medical Care Sees Strong Q3 Margin Growth
Fresenius Medical Care Unveils New Long-Term Incentive Plan
See More Headlines

FMS Stock Analysis - Frequently Asked Questions

Fresenius Medical Care's stock was trading at $20.83 on January 1st, 2024. Since then, FMS stock has increased by 1.8% and is now trading at $21.2150.
View the best growth stocks for 2024 here
.

Fresenius Medical Care AG (NYSE:FMS) posted its earnings results on Wednesday, November, 1st. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.06. The company earned $5.37 billion during the quarter, compared to the consensus estimate of $5.42 billion. Fresenius Medical Care had a trailing twelve-month return on equity of 6.04% and a net margin of 3.43%.

The following companies are subsidiaries of Fresenius Medical Care: NxStage Medical.

Fresenius Medical Care's top institutional shareholders include Pzena Investment Management LLC (2.76%), Moran Wealth Management LLC (0.04%), Crossmark Global Holdings Inc. (0.01%) and QRG Capital Management Inc. (0.01%).

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), General Electric (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
11/01/2023
Today
11/12/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/18/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Employees
1,358
Year Founded
1912

Price Target and Rating

Average Stock Price Target
$24.30
High Stock Price Target
$25.60
Low Stock Price Target
$23.00
Potential Upside/Downside
+14.6%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$540.07 million
Pretax Margin
6.35%

Debt

Sales & Book Value

Annual Sales
$21.05 billion
Cash Flow
$4.60 per share
Book Value
$27.72 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.45 billion
Optionable
Optionable
Beta
0.91

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:FMS) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners